Human Papillomavirus Testing Compared With Cytology for Cervical Cancer Screening Among Women Living With HIV in the Dominican Republic
Authors:
- Margaret M. MadeleineMMMargaret M. Madeleine
- Arismendy Benítez AbreuAAArismendy Benítez Abreu
- Hoisex GomezHGHoisex Gomez
- Estefani Sánchez MarteEMEstefani Sánchez Marte
- María Isabel PerezMPMaría Isabel Perez
- Felix de Jesus Padilla TorresFTFelix de Jesus Padilla Torres
- Angélica MondragónAMAngélica Mondragón
- 1 November 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (11)
Abstract
Purpose: Women living with HIV (WWH) face elevated cervical cancer risk, yet evidence supporting primary human papillomavirus (HPV) testing in low-resource settings remains limited. We compared HPV testing with cytology for detection of cervical precancer among WWH in the Dominican Republic to inform national screening strategies. Methods: In this cross-sectional analysis from US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network Trial 302 (Estudio Oportunidad, ClinicalTrials.gov identifier: NCT05556772 ), 575 WWH contributed provider- and self-collected samples for cytology and HPV hierarchical testing. Women with positive results on cytology, provider-collected HPV testing, or self-collected HPV testing were referred for colposcopy and biopsy. Screening test characteristics were evaluated using centrally adjudicated histologic end points. Results: Women with positive results on any screening test had higher HIV viral loads, lower CD4 counts, and were younger than women with screen-negative results. Sensitivity to detect cervical intraepithelial neoplasia grade 3 (CIN3+) by cytology (66.7% [95% CI, 49.2 to 80.5]) was lower than sensitivity of provider-collected results with either 13 high-risk HPV (hrHPV) genotypes (93.9 [95% CI, 78.7 to 98.5]) or 8 hrHPV genotypes (84.8% [95% CI, 68.3 to 98.6]). Self-collected samples had the highest sensitivity (97.0%, 95% CI, 81.3 to 99.6). Cytology missed 33.3% of CIN3+, hrHPV testing of provider-collected samples missed 6.1%-15.2% of CIN3+, and hrHPV testing of self-collected samples missed 3.0% of CIN3+. Conclusion: Among WWH in the Dominican Republic, HPV testing, whether provider- or self-collected, outperformed cytology for detection of CIN3+. Both 13- and 8-genotype hrHPV panels demonstrated high sensitivity but low specificity, resulting in high referral rates to colposcopy. These findings support transitioning to primary HPV-based screening for WWH in the Dominican Republic to increase accuracy in detecting precancer and reduce the cervical cancer burden among WWH.This publication has 9 references indexed in Scilit:
- Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus–Automated Visual Evaluation ConsortiumJNCI: Journal of the National Cancer Institute, 2025
- A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional studyInternational Journal of Cancer, 2023
- Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysiseClinicalMedicine, 2022
- High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysisInternational Journal of STD & AIDS, 2021
- Estimates of the global burden of cervical cancer associated with HIVThe Lancet Global Health, 2021
- Dominican Provider Practices for Cervical Cancer Screening in Santo Domingo and Monte Plata ProvincesJournal of Cancer Education, 2020
- Cervical cancer risk in women living with HIV across four continents: A multicohort studyInternational Journal of Cancer, 2019
- Cervical cancer screening among transactional female sex workers in the Dominican RepublicInternational Journal of STD & AIDS, 2018
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological FindingsThe Journal of Infectious Diseases, 2010